Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-001357·KYNTRA BIO, INC.
Schedule 13G ownership disclosure
FIBROGEN INC
COM · CUSIP: 31572Q808
Event date: 2024-12-31
- Filing-level shares
- 4,616,130
- Percent of class
- 4.58%
- PRIMECAP MANAGEMENT CO/CA/
Shares: 4,616,130 · Class: 4.58%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-001357
- Form type
- SCHEDULE 13G/A
- Filer
- KYNTRA BIO, INC.
- CIK
- CIK 921299
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership